[2017-2022年江苏省某医院儿科ICU患儿痰培养细菌谱及耐药性变化分析]。

Q3 Medicine
H Huang, J Wei, H J Shen, Q X Tan, J Xue, C Wang
{"title":"[2017-2022年江苏省某医院儿科ICU患儿痰培养细菌谱及耐药性变化分析]。","authors":"H Huang, J Wei, H J Shen, Q X Tan, J Xue, C Wang","doi":"10.3760/cma.j.cn112150-20240514-00386","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To investigate the changes of the distribution and drug resistance profile of bacteria from ICU children with lower respiratory tract infection (LRTI) in Suzhou City, Jiangsu Province from 2017 to 2022. <b>Methods:</b> From January 2017 to December 2022, a cross-sectional observational study on the bacterial spectrum analysis among intensive care unit (ICU) children with LRTI was conducted in Children's Hospital of Soochow University. The bacteria was cultivated by culture methods from sputum samples, and identified by MALDI-TOF mass spectrometry. Drug sensitivity tests were performed by the VITEK2 Compact fully automated analysis system and the paper slide method. The <i>χ</i><sup>2</sup> test or Fisher's exact probability was used to analyze the changes of the distribution of sputum culture-positive bacteria and drug resistance in ICU children. <b>Results:</b> The overall detection rate of sputum culture was 42.06% (1 182/2 810). <i>Staphylococcus aureus</i> (25.63%,303/1 182), <i>Acinetobacter baumannii</i> (13.62%,161/1 182) and <i>Haemaphilus influenzae</i> (13.28%,157/1 182) were the top three. Proportions of <i>Acinetobacter baumannii</i> (17.90% <i>vs.</i> 11.02%,<i>χ</i>²=11.17, <i>P</i>=0.001), especially carbapenem-resistant <i>Acinetobacter baumannii</i> (43.70% <i>vs.</i> 23.50%, <i>χ²</i>=15.21, <i>P</i><0.001) increased significantly from 2020 to 2022. However, the proportions of <i>Haemophilus influenzae</i> (8.50% <i>vs.</i> 16.19%, <i>χ</i>²=14.27, <i>P</i><0.001), <i>Streptococcus pneumoniae</i> (8.50% <i>vs.</i> 15.92%, <i>χ</i>²=13.42, <i>P</i><0.001) and extended-spectrum-lactamase producing <i>Escherichia coli</i> (8.89% <i>vs.</i> 18.00%, <i>χ</i>²=5.45, <i>P</i>=0.025) decreased. Drug resistant results showed that <i>Acinetobacter baumannii</i> was obviously more resistant to imipenem (<i>χ²</i>=4.43, <i>P</i>=0.035) and levofloxacin (<i>χ</i>²=12.53, <i>P</i><0.001), while more sensitive to minocycline (<i>χ</i>²=8.34, <i>P</i>=0.004). Escherichia coli showed a significant increase in resistance to piperacillin tazobactam (<i>χ</i>²=8.29, <i>P</i>=0.008) and cefoperazone sulbactam (<i>χ</i>²=5.07, <i>P</i>=0.024) from 2020 to 2022; Klebsiella pneumoniae consistently maintained a resistance rate of more than 60% to first and second-generation cephalosporins, and remain susceptible to quinolones and carbapenems. Staphylococcus aureus remained highly susceptible to levofloxacin (drug resistance rate: 2.31%,7/303) and sulfamethoxazole/trimethoprim (drug resistance rate: 4.95%,15/303) from 2020 to 2022. <b>Conclusion:</b> Higher detection and resistance rates of <i>Acinetobacter baumannii</i> from sputum culture in ICU children from 2020 to 2022 were explored. Resistance of <i>Escherichia coli</i> to β-lactamase inhibitor combinations was more serious. Regular monitoring the changes of the etiology of respiratory tract infections in ICU Children is particularly important for the prevention and treatment of multidrug-resistant bacterial infections.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"58 10","pages":"1534-1540"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Analysis of the changes of bacterial spectrum and drug resistance in sputum culture of ICU children in a hospital of pediatric in Jiangsu Province from 2017 to 2022].\",\"authors\":\"H Huang, J Wei, H J Shen, Q X Tan, J Xue, C Wang\",\"doi\":\"10.3760/cma.j.cn112150-20240514-00386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> To investigate the changes of the distribution and drug resistance profile of bacteria from ICU children with lower respiratory tract infection (LRTI) in Suzhou City, Jiangsu Province from 2017 to 2022. <b>Methods:</b> From January 2017 to December 2022, a cross-sectional observational study on the bacterial spectrum analysis among intensive care unit (ICU) children with LRTI was conducted in Children's Hospital of Soochow University. The bacteria was cultivated by culture methods from sputum samples, and identified by MALDI-TOF mass spectrometry. Drug sensitivity tests were performed by the VITEK2 Compact fully automated analysis system and the paper slide method. The <i>χ</i><sup>2</sup> test or Fisher's exact probability was used to analyze the changes of the distribution of sputum culture-positive bacteria and drug resistance in ICU children. <b>Results:</b> The overall detection rate of sputum culture was 42.06% (1 182/2 810). <i>Staphylococcus aureus</i> (25.63%,303/1 182), <i>Acinetobacter baumannii</i> (13.62%,161/1 182) and <i>Haemaphilus influenzae</i> (13.28%,157/1 182) were the top three. Proportions of <i>Acinetobacter baumannii</i> (17.90% <i>vs.</i> 11.02%,<i>χ</i>²=11.17, <i>P</i>=0.001), especially carbapenem-resistant <i>Acinetobacter baumannii</i> (43.70% <i>vs.</i> 23.50%, <i>χ²</i>=15.21, <i>P</i><0.001) increased significantly from 2020 to 2022. However, the proportions of <i>Haemophilus influenzae</i> (8.50% <i>vs.</i> 16.19%, <i>χ</i>²=14.27, <i>P</i><0.001), <i>Streptococcus pneumoniae</i> (8.50% <i>vs.</i> 15.92%, <i>χ</i>²=13.42, <i>P</i><0.001) and extended-spectrum-lactamase producing <i>Escherichia coli</i> (8.89% <i>vs.</i> 18.00%, <i>χ</i>²=5.45, <i>P</i>=0.025) decreased. Drug resistant results showed that <i>Acinetobacter baumannii</i> was obviously more resistant to imipenem (<i>χ²</i>=4.43, <i>P</i>=0.035) and levofloxacin (<i>χ</i>²=12.53, <i>P</i><0.001), while more sensitive to minocycline (<i>χ</i>²=8.34, <i>P</i>=0.004). Escherichia coli showed a significant increase in resistance to piperacillin tazobactam (<i>χ</i>²=8.29, <i>P</i>=0.008) and cefoperazone sulbactam (<i>χ</i>²=5.07, <i>P</i>=0.024) from 2020 to 2022; Klebsiella pneumoniae consistently maintained a resistance rate of more than 60% to first and second-generation cephalosporins, and remain susceptible to quinolones and carbapenems. Staphylococcus aureus remained highly susceptible to levofloxacin (drug resistance rate: 2.31%,7/303) and sulfamethoxazole/trimethoprim (drug resistance rate: 4.95%,15/303) from 2020 to 2022. <b>Conclusion:</b> Higher detection and resistance rates of <i>Acinetobacter baumannii</i> from sputum culture in ICU children from 2020 to 2022 were explored. Resistance of <i>Escherichia coli</i> to β-lactamase inhibitor combinations was more serious. Regular monitoring the changes of the etiology of respiratory tract infections in ICU Children is particularly important for the prevention and treatment of multidrug-resistant bacterial infections.</p>\",\"PeriodicalId\":24033,\"journal\":{\"name\":\"中华预防医学杂志\",\"volume\":\"58 10\",\"pages\":\"1534-1540\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华预防医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn112150-20240514-00386\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华预防医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112150-20240514-00386","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的研究2017-2022年江苏省苏州市ICU患儿下呼吸道感染(LRTI)细菌分布及耐药谱的变化。方法:从 2017 年 1 月至 2022 年 12 月,对江苏省苏州市 ICU 下呼吸道感染患儿的细菌分布和耐药性情况进行调查:2017年1月至2022年12月,在苏州大学附属儿童医院开展了一项关于重症监护病房(ICU)下呼吸道感染患儿细菌谱分析的横断面观察研究。通过培养方法从痰液样本中培养细菌,并通过 MALDI-TOF 质谱法进行鉴定。药敏试验采用 VITEK2 Compact 全自动分析系统和纸片法进行。采用χ2检验或费雪精确概率分析ICU患儿痰培养阳性菌分布和耐药性的变化。结果痰培养总检出率为 42.06%(1 182/2 810)。金黄色葡萄球菌(25.63%,303/1 182)、鲍曼不动杆菌(13.62%,161/1 182)和流感嗜血杆菌(13.28%,157/1 182)位居前三位。鲍曼不动杆菌(17.90% vs. 11.02%,χ²=11.17,P=0.001),尤其是耐碳青霉烯鲍曼不动杆菌(43.70% vs. 23.50%,χ²=15.21, PHaemophilus influenzae (8.50% vs. 16.19%, χ²=14.27, PStreptococcus pneumoniae (8.50% vs. 15.92%, χ²=13.42, PEscherichia coli (8.89% vs. 18.00%, χ²=5.45, P=0.025)下降。耐药性结果显示,鲍曼不动杆菌对亚胺培南(χ²=4.43,P=0.035)和左氧氟沙星(χ²=12.53,Pχ²=8.34,P=0.004)的耐药性明显更强。从 2020 年到 2022 年,大肠埃希菌对哌拉西林他唑巴坦(χ²=8.29,P=0.008)和头孢哌酮舒巴坦(χ²=5.07,P=0.024)的耐药性显著增加;肺炎克雷伯菌对第一代和第二代头孢菌素的耐药率始终保持在 60% 以上,对喹诺酮类和碳青霉烯类仍然易感。从 2020 年到 2022 年,金黄色葡萄球菌对左氧氟沙星(耐药率:2.31%,7/303)和磺胺甲恶唑/三甲氧苄啶(耐药率:4.95%,15/303)仍然高度敏感。结论探讨了 2020 年至 2022 年 ICU 儿童痰培养中鲍曼不动杆菌更高的检出率和耐药率。大肠埃希菌对β-内酰胺酶抑制剂复方制剂的耐药性更为严重。定期监测重症监护室儿童呼吸道感染病因的变化对于预防和治疗耐多药细菌感染尤为重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Analysis of the changes of bacterial spectrum and drug resistance in sputum culture of ICU children in a hospital of pediatric in Jiangsu Province from 2017 to 2022].

Objective: To investigate the changes of the distribution and drug resistance profile of bacteria from ICU children with lower respiratory tract infection (LRTI) in Suzhou City, Jiangsu Province from 2017 to 2022. Methods: From January 2017 to December 2022, a cross-sectional observational study on the bacterial spectrum analysis among intensive care unit (ICU) children with LRTI was conducted in Children's Hospital of Soochow University. The bacteria was cultivated by culture methods from sputum samples, and identified by MALDI-TOF mass spectrometry. Drug sensitivity tests were performed by the VITEK2 Compact fully automated analysis system and the paper slide method. The χ2 test or Fisher's exact probability was used to analyze the changes of the distribution of sputum culture-positive bacteria and drug resistance in ICU children. Results: The overall detection rate of sputum culture was 42.06% (1 182/2 810). Staphylococcus aureus (25.63%,303/1 182), Acinetobacter baumannii (13.62%,161/1 182) and Haemaphilus influenzae (13.28%,157/1 182) were the top three. Proportions of Acinetobacter baumannii (17.90% vs. 11.02%,χ²=11.17, P=0.001), especially carbapenem-resistant Acinetobacter baumannii (43.70% vs. 23.50%, χ²=15.21, P<0.001) increased significantly from 2020 to 2022. However, the proportions of Haemophilus influenzae (8.50% vs. 16.19%, χ²=14.27, P<0.001), Streptococcus pneumoniae (8.50% vs. 15.92%, χ²=13.42, P<0.001) and extended-spectrum-lactamase producing Escherichia coli (8.89% vs. 18.00%, χ²=5.45, P=0.025) decreased. Drug resistant results showed that Acinetobacter baumannii was obviously more resistant to imipenem (χ²=4.43, P=0.035) and levofloxacin (χ²=12.53, P<0.001), while more sensitive to minocycline (χ²=8.34, P=0.004). Escherichia coli showed a significant increase in resistance to piperacillin tazobactam (χ²=8.29, P=0.008) and cefoperazone sulbactam (χ²=5.07, P=0.024) from 2020 to 2022; Klebsiella pneumoniae consistently maintained a resistance rate of more than 60% to first and second-generation cephalosporins, and remain susceptible to quinolones and carbapenems. Staphylococcus aureus remained highly susceptible to levofloxacin (drug resistance rate: 2.31%,7/303) and sulfamethoxazole/trimethoprim (drug resistance rate: 4.95%,15/303) from 2020 to 2022. Conclusion: Higher detection and resistance rates of Acinetobacter baumannii from sputum culture in ICU children from 2020 to 2022 were explored. Resistance of Escherichia coli to β-lactamase inhibitor combinations was more serious. Regular monitoring the changes of the etiology of respiratory tract infections in ICU Children is particularly important for the prevention and treatment of multidrug-resistant bacterial infections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
中华预防医学杂志
中华预防医学杂志 Medicine-Medicine (all)
CiteScore
1.20
自引率
0.00%
发文量
12678
期刊介绍: Chinese Journal of Preventive Medicine (CJPM), the successor to Chinese Health Journal , was initiated on October 1, 1953. In 1960, it was amalgamated with the Chinese Medical Journal and the Journal of Medical History and Health Care , and thereafter, was renamed as People’s Care . On November 25, 1978, the publication was denominated as Chinese Journal of Preventive Medicine . The contents of CJPM deal with a wide range of disciplines and technologies including epidemiology, environmental health, nutrition and food hygiene, occupational health, hygiene for children and adolescents, radiological health, toxicology, biostatistics, social medicine, pathogenic and epidemiological research in malignant tumor, surveillance and immunization.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信